NCT01242605 ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer Status COMPLETED Phase PHASE1
NCT01213758 Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT Status COMPLETED Phase N/A
NCT01206049 Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations Status COMPLETED Phase PHASE2
NCT01151761 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Status TERMINATED Phase PHASE2
NCT01135732 Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy Status COMPLETED Phase N/A
NCT01043172 A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection Status COMPLETED Phase PHASE2
NCT01007552 A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts Status COMPLETED Phase PHASE2
NCT00975039 Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT00955721 A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00955149 Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) Status COMPLETED Phase PHASE1
NCT00948935 Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00907413 Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma Status TERMINATED Phase PHASE3
NCT00797121 Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma Status UNKNOWN Phase PHASE4
NCT00779454 Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT00733200 Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? Status COMPLETED Phase NA
NCT00713687 Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma Status WITHDRAWN Phase PHASE2